Skip to main content
S 274 112th Congress Senate Health Drug therapy Health care quality Medicaid Medicare Performance measurement

Medication Therapy Management Empowerment Act of 2011

Introduced: February 3, 2011 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 3, 2011
Read twice and referred to the Committee on Finance.
Feb 3, 2011
Sponsor introductory remarks on measure. (CR S546-547)
Feb 3, 2011
Introduced in Senate
 Plain-English summary Congressional Research Service

Medication Therapy Management Empowerment Act of 2011 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA), as amended by the Patient Protection and Affordable Care Act, to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management (MTM) services.

Requires a Prescription Drug Plan (PDP) sponsor to establish a process, subject to approval by the Secretary of Health and Human Services (HHS), for identifying individuals who are not targeted beneficiaries, are not otherwise offered MTM services, and whom a pharmacist or other qualified provider determines may benefit from MTM services. Requires any such individual to be treated as a targeted beneficiary.

Requires any MTM program to offer both comprehensive and targeted medication reviews to individuals dually eligible for both Medicare and Medicaid (under SSA title XIX), regardless of whether they are MTM-targeted beneficiaries.

Requires a PDP sponsor to offer any willing pharmacy in its network and any other qualified health care provider the opportunity to provide MTM services.

Requires the PDP sponsor to reimburse pharmacists and other qualified health care providers furnishing MTM services based on the resources used and the time required to provide such services.

Directs the Secretary of HHS to: (1) establish measures and standards for data collection by PDP sponsors to evaluate performance of pharmacies and other entities in furnishing MTM services; and (2) support the continued development and refinement of performance measures.

Provides pharmacies and other entities that furnish MTM services with additional incentive payments based on their performance in meeting quality measures established under this Act.

What's happening now February 3, 2011

Read twice and referred to the Committee on Finance.

 Committees of jurisdiction 1